March 20, 2025 – Austin, Texas – BrainCheck, a leading innovator in digital cognitive health solutions, is proud to announce that it has been awarded a pilot grant from the Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging (PennAITech). This grant, part of PennAITech’s recent $2.37 million funding initiative,1 will support BrainCheck’s development of an AI-driven chatbot designed to assist individuals with Alzheimer’s Disease and Related Dementias (AD/ADRD) in navigating their cognitive care plans.
With cognitive decline affecting millions of individuals and early detection being critical to improving patient outcomes, BrainCheck’s platform provides a comprehensive solution. Offering accurate cognitive assessments from any device, at any time, and from anywhere, BrainCheck ensures that clinicians and caregivers are equipped with the tools to detect impairment early and take immediate action.
In 2019, BrainCheck introduced the pioneering computerized cognitive care planning (CCP) tool, BrainCheck Plan. BrainCheck Plan streamlines the assessment of patients’ and caregivers’ care needs and automates the generation of personalized cognitive care plans, thus improving the accessibility of CCP to benefit more patients. To date, 93 clinics across the US are using BrainCheck Plan, and 23,379 care plans have been generated.
Although providers can review care plans with patients and caregivers during visits,2 there remains a critical gap in continuous support for patients and caregivers beyond the clinical setting. The AI-driven chatbot will extend cognitive care into the home, providing real-time, AI-powered assistance to help individuals adhere to their care plans, access relevant resources, and receive timely guidance between clinical visits.
“We are thrilled to partner with PennAITech to develop AI-driven solutions that bridge the gap between clinical visits and everyday life for those living with cognitive impairment,” said Mary Patterson, Vice President of Clinical Operations at BrainCheck. “By integrating AI into cognitive care, we can provide patients and caregivers with accessible, real-time support, ensuring that critical care guidance extends beyond the walls of the clinic.”
Dr. George Demiris, Co-Principal Investigator of PennAITech, underscored the importance of AI in enhancing aging and dementia care. “We fund a broad spectrum of approaches, technologies and systems that foster innovation. We are looking forward to working with all our awardees to create new solutions for aging.”1
This collaboration marks an important step toward leveraging AI to bridge critical care gaps for individuals living with cognitive impairment. By utilizing innovative digital tools, BrainCheck and PennAITech—alongside key collaborators Co-PI Katherine Britt, PhD, MSN (University of Iowa), Co-I Xiao Luo, PhD (Oklahoma State University), and Co-I Rebecca T. Brown, MD, MPH (Perelman School of Medicine, University of Pennsylvania)—are focused on improving the accessibility and effectiveness of dementia care. This partnership underscores the growing role of technology in addressing the increasing demand for scalable, personalized healthcare solutions, ensuring that individuals with cognitive decline receive the continuous support they need anytime, anywhere.
BrainCheck has been awarded a portion of the $2.37 million grant funding, which will be dedicated to developing the AI-driven chatbot for cognitive care. For updates on the development of the AI-driven chatbot or to learn more about how BrainCheck is revolutionizing cognitive care, visit our website at www.braincheck.com or reach out to our media team.
About PennAITech
The Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging (PennAITech) is a National Institute on Aging-funded initiative dedicated to developing cutting-edge AI and technology solutions to support older adults, particularly those with cognitive impairment and dementia. Based at the University of Pennsylvania, PennAITech brings together leading researchers, clinicians, engineers, and industry partners to explore and implement innovative healthcare technologies that enhance aging-related care. For more information visit https://www.pennaitech.org/.
About BrainCheck
BrainCheck is revolutionizing cognitive healthcare with an easy-to-use, FDA Class II digital cognitive assessment platform that works on any device. Designed to integrate seamlessly into clinical workflows, BrainCheck empowers healthcare providers to screen, assess, and monitor cognitive health efficiently. With superior UX, top-tier clinical validation, and robust EHR integrations, BrainCheck enhances care delivery and improves patient outcomes. Trusted by leading healthcare organizations and aligned with global research initiatives, BrainCheck is committed to making cognitive health a priority for patients and providers alike.
Media Contact
Hope Fowler
Marketing Manager
BrainCheck, Inc.
hope.fowler@braincheck.com
References:
- Demiris G, Karlawish J. PennAITech awards $2.3 million for AI research to support aging. Penn Nursing News. March 6, 2025.
- Kim SK, Park M. Effectiveness of person-centered care on people with dementia: a systematic review and meta-analysis. Clin Interv Aging. 2017;12:381–397. PMCID: PMC5322939
